Emerald Leaves LLC – Trademark Portfolio

Entity Type: 16

Emerald Leaves LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ZIPS CANNABIS and EMERALD LEAVES. The owner is based in Seattle, WA.

10423 Forest Ave. S

Seattle, WA 92627

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Emerald Leaves LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (3 filings)

Advertising; business management; business administration; office functions

41
Education & Entertainment (3 filings)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Emerald Leaves LLC have?

Emerald Leaves LLC has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 abandoned.

What trademark classes does Emerald Leaves LLC file in?

Emerald Leaves LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.

What are Emerald Leaves LLC's most well-known trademarks?

Emerald Leaves LLC's registered trademark portfolio includes well-known marks such as ZIPS CANNABIS and EMERALD LEAVES. These are among 3 currently registered trademarks in the portfolio.

What is Emerald Leaves LLC's trademark registration success rate?

Emerald Leaves LLC has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.